Generic name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4ug in 0.5mL
Dosage form: solution for intramuscular injection
Drug class: Bacterial vaccines
Medically reviewed by Drugs.com. Last updated on Jan 22, 2024.
Preparation for Administration
Menactra is a clear to slightly turbid solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If any of these conditions exist, the vaccine should not be administered.
Withdraw the 0.5 mL dose of vaccine from the single-dose vial using a sterile needle and syringe.
Dose and Schedule
Menactra is administered as a 0.5 mL dose by intramuscular injection. Do not administer this product intravenously or subcutaneously.
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart.
- Individuals 2 through 55 years of age, Menactra is given as a single dose.
More about Menactra (meningococcal conjugate vaccine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: bacterial vaccines
- En español
- Menactra drug information
- Menactra (Meningococcal polysaccharide vaccine, diphtheria conjugate Intramuscular) (Advanced Reading)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.